Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $17.9 million.

  • Praxis Precision Medicines' Shares Outstanding (Diluted Average) rose 16.38% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year increase of 16.38%. This contributed to the annual value of $17.9 million for FY2024, which is 171.55% up from last year.
  • According to the latest figures from FY2024, Praxis Precision Medicines' Shares Outstanding (Diluted Average) is $17.9 million, which was up 171.55% from $6.6 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Shares Outstanding (Diluted Average) ranged from a high of $17.9 million in FY2024 and a low of $3.1 million during FY2022.
  • In the last 3 years, Praxis Precision Medicines' Shares Outstanding (Diluted Average) had a median value of $6.6 million in 2023 and averaged $9.2 million.
  • Data for Praxis Precision Medicines' Shares Outstanding (Diluted Average) shows a peak YoY soared of 171.55% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Praxis Precision Medicines' Shares Outstanding (Diluted Average) stood at $3.1 million in 2022, then soared by 114.58% to $6.6 million in 2023, then surged by 171.55% to $17.9 million in 2024.